DBG
DGX icon

De Burlo Group’s Quest Diagnostics DGX Stock Holding History

De Burlo Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-77,800
Closed -$8.65M – 107
2017
Q2 		$8.65M Buy
77,800
+8,300
+12% +$878K 1.93% 21
2017
Q1 		$6.82M Sell
69,500
-19,500
-22% -$1.86M 1.48% 28
2016
Q4 		$8.18M Buy
89,000
+16,000
+22% +$1.38M 1.99% 18
2016
Q3 		$6.18M Sell
73,000
-13,300
-15% -$1.12M 1.71% 21
2016
Q2 		$7.03M Buy
86,300
+28,700
+50% +$2.19M 1.7% 24
2016
Q1 		$4.12M Sell
57,600
-6,500
-10% -$436K 1.19% 36
2015
Q4 		$4.56M Sell
64,100
-51,400
-45% -$3.46M 1.07% 40
2015
Q3 		$7.1M Sell
115,500
-200
-0.2% -$14K 1.67% 24
2015
Q2 		$8.39M Buy
115,700
+100
+0.1% +$7.38K 1.76% 21
2015
Q1 		$8.88M Buy
+115,600
New +$8.28M 1.76% 16

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

De Burlo Group's DGX Position: Q3 2017 in Review

De Burlo Group sold out of Quest Diagnostics (DGX) in Q3 2017, closing a stake of 77,800 shares — an estimated $8.65M sold.

De Burlo Group first reported a position in DGX in Q1 2015 and held it in 10 quarters. The position peaked at $8.88M in Q1 2015. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

  • De Burlo Group reported no remaining Quest Diagnostics position as of Q3 2017 after selling out during the quarter.
  • De Burlo Group sold 77,800 Quest Diagnostics shares in Q3 2017, an estimated $8.65M.
  • De Burlo Group first reported a position in Quest Diagnostics in Q1 2015 and held it in 10 quarters.
  • De Burlo Group's Quest Diagnostics position peaked at $8.88M in Q1 2015.
  • 616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on De Burlo Group's 13F filing for Q3 2017, filed 2 Nov 2017.